Same industry

ADMA against four biotech peers, a year at 100

50100200400800Feb ’26MayAugNov ’26AMGN+31.5%GILD+33.4%MRNA×8.3BIIB+43.4%ADMA−21.1%

ADMA −21.1%. Moderna ×8.3, Biogen +43.4%, Gilead Sciences +33.4%, Amgen +31.5%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ADMA’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

ADMA: stories, the record and filings →